// App-Quantinova.ai

: Feasibility of High Doses Peg-Asparaginase Administration in a Cohort of Adult Acute Lymphoblastic Leukemia Patients

Researchers

Presenter

  • Paola Minetto

Principal Investigators

  • Nadia Bisso

  • Fabio Guolo

  • Marino Clavio

  • Riccardo Marcolin

  • Filippo Ballerini

  • Maurizio Miglino

  • Marco Gobbi

  • Roberto Massimo Lemoli

Medical Centers

  • N/A

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • PEG-asparaginase

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved